All Stories

  1. Effect of Electromagnetic Waves from Mobile Phones on Spermatogenesis in the Era of 4G-LTE
  2. Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment
  3. Preoperative Serum Sex Hormone-Binding Globulin Level Is an Independent Predictor of Biochemical Outcome After Radical Prostatectomy
  4. A propensity-matched comparison of perioperative complications and of chronic kidney disease between robot-assisted laparoscopic partial nephrectomy and radiofrequency ablative therapy
  5. Clinical Value of Core Length in Contemporary Multicore Prostate Biopsy
  6. MP44-09 DOES WARM ISCHEMIC TIME REALLY AFFECT THE LATE KIDNEY FUNCTION AND OVERALL SURVIVAL AFTER PARTIAL NEPHRECTOMY?
  7. Stratification of patients with intermediate‐risk prostate cancer
  8. The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance
  9. Stratification of Contemporary Patients Undergoing Radical Prostatectomy for High-risk Prostate Cancer
  10. Impact of Prostatic Apical Shape and Protrusion on Early Recovery of Continence After Robot-assisted Radical Prostatectomy
  11. Insignificant disease among men with intermediate-risk prostate cancer
  12. Definitive Pathology at Radical Prostatectomy Is Commonly Favorable in Men Following Initial Active Surveillance
  13. Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
  14. Comparison of robotic and open partial nephrectomy: Single-surgeon matched cohort study
  15. Prostate Size and Adverse Pathologic Features in Men Undergoing Radical Prostatectomy
  16. Dilemmas Over the Decision to Perform Repeat Prostate Biopsies
  17. Kallikreins as Biomarkers for Prostate Cancer
  18. Localization of higher grade tumor foci in potential candidates for active surveillance who opt for radical prostatectomy
  19. 622 THE RESTORATIVE CHANGES IN RENAL FUNCTION AFTER RADICAL NEPHRECTOMY: A 5-YEAR FOLLOW-UP SERIAL ASSESSMENT, AND A MULTICENTER BASED STUDY
  20. Efficacy and tolerability of combined medication of two different antimuscarinics for treatment of adults with idiopathic overactive bladder in whom a single agent antimuscarinic therapy failed
  21. Urinary continence after radical prostatectomy: Predictive factors of recovery after 1 year of surgery
  22. Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity
  23. The prognostic significance of percentage of tumour involvement according to disease risk group in men treated with radical prostatectomy
  24. Significance of smoking status regarding outcomes after radical prostatectomy
  25. Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?
  26. The 5-year functional outcomes after radical prostatectomy: a real-life experience in Korea
  27. Prognostic Significance of Undetectable Ultrasensitive Prostate-specific Antigen Nadir After Radical Prostatectomy
  28. 974 TRICHOSTATIN A MEDIATED RESENSITIZATION OF CHEMO-RESISTANT T24R2 HUMAN BLADDER CANCER CELL LINE TO CISPLATIN
  29. Effect of the dual 5α-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia
  30. 971 COMBINED TREATMENT WITH CISPLATIN AND DUAL PI3K-MTOR INHIBITOR NVP-BEZ235 CAN RESTORE CASPASE DEPENDENT APOPTOSIS IN CISPLATIN RESISTANT HUMAN BLADDER CANCER CELL THROUGH THE DOWN-REGULATION OF C-FLIP
  31. 400 PROGNOSTIC SIGNIFICANCE OF UNDETECTABLE ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN NADIR AFTER RADICAL PROSTATECTOMY
  32. 142 USAGE OF EPSTEIN CRITERIA FOR PREDICTION OF CLINICALLY INSIGNIFICANT PROSTATE CANCER IN KOREAN MEN
  33. Survival Analysis of Intrahepatic Cholangiocarcinoma After Resection
  34. Comparison of radiographic and pathologic sizes of renal tumors
  35. Urodynamic and Histological Changes in a Sterile Rabbit Vesicoureteral Reflux Model
  36. Alteration of Antithrombin III and D-dimer Levels in Clinically Localized Prostate Cancer
  37. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia
  38. Effect of bony pelvic dimensions measured by preoperative magnetic resonance imaging on performing robot-assisted laparoscopic prostatectomy
  39. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer
  40. SIGNIFICANCE OF PREOPERATIVE HBA1C LEVEL IN PATIENTS WITH DIABETES MELLITUS AND CLINICALLY LOCALIZED PROSTATE CANCER
  41. PREDICTION OF GLEASON SCORE UPGRADING IN LOW RISK PROSTATE CANCERS DIAGNOSED VIA MULTI (≥ 12)-CORE PROSTATE BIOPSY
  42. ARE RISK FACTORS FOR FAILURE AFTER MID-URETHRAL SLING OPERATION DIFFERENT BETWEEN PURE STRESS AND MIXED URINARY INCONTINENCE?
  43. PATHOLOGIC OUTCOME OF UNILATERAL LOW RISK PROSTATE CANCERS ON MULTI-(≥ 12) CORE PROSTATE BIOPSY AFTER RADICAL PROSTATECTOMY
  44. Predictive Factors for Female Bladder Outlet Obstruction Defined by Pressure-Flow Study
  45. Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (≥12)-core prostate biopsy
  46. Periprostatic Distribution of Nerves in Specimens From Non–nerve-sparing Radical Retropubic Prostatectomy
  47. Relationship Between Lower Urinary Tract Symptoms and Metabolic Syndrome in a Community-based Elderly Population
  48. Relationship of Prostate-Specific Antigen and Prostate Volume in Korean Men with Biopsy-Proven Benign Prostatic Hyperplasia
  49. Association of Prostate Size and Tumor Grade in Korean Men with Clinically Localized Prostate Cancer
  50. Impact of Variations in Bony Pelvic Dimensions on Performing Radical Retropubic Prostatectomy
  51. Significance of Neurovascular Bundle Formation Observed on Preoperative Magnetic Resonance Imaging Regarding Postoperative Erectile Function After Nerve-Sparing Radical Retropubic Prostatectomy
  52. The Characteristics of Prostate Cancer with Metabolic Syndrome in Korean Men
  53. Pathological Characteristics of Neuroendocrine Cell Differentiation in Prostate Cancer
  54. The Relationship of Prostate Volume and the Grade of Prostate Cancer
  55. Prospective Analysis on the Relation between Pain and Prostate Volume during Transrectal Prostate Biopsy
  56. Significance of Macroscopic Tumor Necrosis as a Prognostic Indicator for Renal Cell Carcinoma
  57. Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy
  58. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma
  59. Metastatectomy prior to Immunochemotherapy for Metastatic Renal Cell Carcinoma
  60. Clinical Significance of a Single-Core Positive Prostate Cancers Detected on Extended Prostate Needle Biopsy
  61. Diagnostic Value of Systematic Sextant and Lesion Directed Biopsy Regimen in Patients with Suspicious Lesions on Transrectal Ultrasonography
  62. Adjuvant interleukin-2, interferon-alpha, and 5-fluorouracil immunochemotherapy after radical nephrectomy for locally advanced renal cell carcinoma
  63. Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?
  64. A case of renal transitional cell carcinoma associated with synchronous contralateral renal cell carcinoma